[HTML][HTML] Yttrium-90 transarterial radioembolization versus conventional transarterial chemoembolization for patients with hepatocellular carcinoma: a systematic …
Y Yang, T Si - Cancer biology & medicine, 2018 - ncbi.nlm.nih.gov
Objective: To compare the effects and safety of conventional transarterial
chemoembolization (cTACE) and yttrium-90 transarterial radioembolization [TARE (90Y)] for …
chemoembolization (cTACE) and yttrium-90 transarterial radioembolization [TARE (90Y)] for …
Yttrium-90 radioembolization is associated with better clinical outcomes in patients with hepatocellular carcinoma compared with conventional chemoembolization: a …
MA Kim, H Jang, NR Choi, JY Nam… - Journal of …, 2021 - Taylor & Francis
Background Both trans-arterial radioembolization (TARE) and conventional trans-arterial
chemoembolization (TACE) can effectively control hepatocellular carcinoma (HCC) in …
chemoembolization (TACE) can effectively control hepatocellular carcinoma (HCC) in …
[HTML][HTML] Effect of Yttrium-90 transarterial radioembolization in patients with non-surgical hepatocellular carcinoma: A systematic review and meta-analysis
Background Recently, the use of Yttrium-90 transarterial radioembolization in non-surgical
hepatocellular carcinoma was suggested but the evidence supporting its use is unclear …
hepatocellular carcinoma was suggested but the evidence supporting its use is unclear …
[HTML][HTML] Transarterial radioembolization vs chemoembolization for hepatocarcinoma patients: a systematic review and meta-analysis
A Facciorusso, G Serviddio… - World journal of …, 2016 - ncbi.nlm.nih.gov
AIM: To compare the efficacy and safety of yttrium-90 radioembolization (Y90RE) and
transarterial chemoembolization (TACE) in hepatocellular carcinoma patients. METHODS …
transarterial chemoembolization (TACE) in hepatocellular carcinoma patients. METHODS …
Transarterial Y90 radioembolization versus chemoembolization for patients with hepatocellular carcinoma: a meta-analysis
Transarterial chemoembolization (TACE) is one of the standard locoregional treatments for
intermediate stage hepatocellular carcinoma (HCC). Transarterial radioembolization (TARE) …
intermediate stage hepatocellular carcinoma (HCC). Transarterial radioembolization (TARE) …
[HTML][HTML] Transarterial radioembolization versus chemoembolization for the treatment of hepatocellular carcinoma (TRACE): study protocol for a randomized controlled …
BA Seinstra, L Defreyne, B Lambert, MG Lam… - Trials, 2012 - Springer
Background Hepatocellular carcinoma is a primary malignant tumor of the liver that accounts
for an important health problem worldwide. Only 10 to 15% of hepatocellular carcinoma …
for an important health problem worldwide. Only 10 to 15% of hepatocellular carcinoma …
90Y Radioembolization versus Drug-eluting Bead Chemoembolization for Unresectable Hepatocellular Carcinoma: Results from the TRACE …
E Dhondt, B Lambert, L Hermie, L Huyck… - Radiology, 2022 - pubs.rsna.org
Background Transarterial chemoembolization (TACE) is the recommended treatment for
intermediate hepatocellular carcinoma (HCC) according to the Barcelona Clinic Liver …
intermediate hepatocellular carcinoma (HCC) according to the Barcelona Clinic Liver …
Efficacy and safety of transarterial radioembolization versus chemoembolization in patients with hepatocellular carcinoma
LE Moreno-Luna, JD Yang, W Sanchez… - Cardiovascular and …, 2013 - Springer
Purpose Intermediate-stage hepatocellular carcinoma (HCC) is usually treated with
locoregional therapy using transarterial chemoembolization (TACE). Transarterial …
locoregional therapy using transarterial chemoembolization (TACE). Transarterial …
Meta-analysis: adjusted indirect comparison of drug-eluting bead transarterial chemoembolization versus 90Y-radioembolization for hepatocellular carcinoma
Objective To investigate comparative effectiveness of drug-eluting bead transarterial
chemoembolization (DEB-TACE) versus Yttrium-90 (90 Y)-radioembolization for …
chemoembolization (DEB-TACE) versus Yttrium-90 (90 Y)-radioembolization for …
TACE versus TARE for patients with hepatocellular carcinoma: overall and individual patient level meta analysis
AM Brown, I Kassab, M Massani, W Townsend… - Cancer …, 2023 - Wiley Online Library
Background Transarterial radioembolization (TARE) is increasingly used as an alternative to
transarterial chemoembolization (TACE) for the treatment of hepatocellular carcinoma …
transarterial chemoembolization (TACE) for the treatment of hepatocellular carcinoma …
Related searches
- transarterial radioembolization hepatocellular carcinoma
- transarterial radioembolization meta analysis
- hepatocellular carcinoma meta analysis
- transarterial radioembolization chemoembolization in patients
- hepatocellular carcinoma chemoembolization in patients
- chemoembolization for patients meta analysis
- hepatocellular carcinoma efficacy and safety
- transarterial radioembolization treatment modality
- transarterial radioembolization efficacy and safety
- hepatocellular carcinoma treatment modality
- chemoembolization in patients efficacy and safety
- hepatocellular carcinoma transarterial chemoembolization
- transarterial radioembolization chemoembolization for the treatment
- transarterial radioembolization hepatocarcinoma patients
- hepatocellular carcinoma chemoembolization for the treatment
- hepatocarcinoma patients meta analysis